Mi Deng

11PUBLICATIONS

44CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 24, 2026

Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells.

|May 18, 2026

Systematic functional screening of immunoreceptor tyrosine-based inhibitory motif domains identifies potent inhibitory modules for chimeric antigen receptor-T.

|Apr 21, 2026

Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma.

|Mar 03, 2026

In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy.

Binlong Chen, Fangjie Wan, Heming Xia

|Mar 27, 2025

Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

|Dec 19, 2023

LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.

Ryan Huang, Xiaoye Liu, Jaehyup Kim

Pageof 2

Frequent Collaborators

Ningyan Zhang

Zhiqiang An

Cheryl Lewis

Yasuaki Anami

Kyoji Tsuchikama

Jingjing Xie

Wei Xiong

Jianbo Wu

Ryan Huang

Xiaoye Liu

Frequent Collaborators

Ningyan Zhang

Zhiqiang An

Cheryl Lewis

Yasuaki Anami